ID: ALA5187414

Max Phase: Preclinical

Molecular Formula: C18H19FN4O2

Molecular Weight: 342.37

Associated Items:

Representations

Canonical SMILES:  Cn1ccc2ncnc(Nc3ccc(F)cc3O[C@@H]3CCCOC3)c21

Standard InChI:  InChI=1S/C18H19FN4O2/c1-23-7-6-15-17(23)18(21-11-20-15)22-14-5-4-12(19)9-16(14)25-13-3-2-8-24-10-13/h4-7,9,11,13H,2-3,8,10H2,1H3,(H,20,21,22)/t13-/m1/s1

Standard InChI Key:  WSLNKDCNHNOGHL-CYBMUJFWSA-N

Associated Targets(Human)

MAP kinase signal-integrating kinase 2 3518 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MAP kinase-interacting serine/threonine-protein kinase MNK1 2071 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Eukaryotic translation initation factor 600 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 342.37Molecular Weight (Monoisotopic): 342.1492AlogP: 3.41#Rotatable Bonds: 4
Polar Surface Area: 61.20Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.97CX LogP: 3.20CX LogD: 3.20
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.79Np Likeness Score: -0.84

References

1. Xu W, Kannan S, Verma CS, Nacro K..  (2022)  Update on the Development of MNK Inhibitors as Therapeutic Agents.,  65  (2.0): [PMID:34533957] [10.1021/acs.jmedchem.1c00368]

Source